Moderna’s new vaccine targets COVID-19, the flu, and RSV
Moderna is developing a combination vaccine to protect against COVID-19, seasonal influenza, and respiratory syncytial virus.
Molecular farming could be the future of vaccines
Edible plant-based vaccines could revolutionize how we fight diseases.
UK researchers are growing the Delta variant for human challenge trials
Responding to the variant’s rise, UK researchers are growing the Delta variant for trials.
India’s DNA vaccine for COVID-19 gets emergency approval
India has granted emergency approval to the world's first DNA vaccine for COVID-19.
Ancient frozen viruses hold clues to life and climate
Using new techniques, researchers at Ohio State have identified ancient viruses we’ve never seen before.
Pfizer’s RSV vaccine 100% effective in human challenge trial
An RSV vaccine developed by Pfizer was reportedly 100% effective in a small human challenge trial and caused minimal side effects.
Pfizer has manufactured the first batch of Delta variant vaccines
Pharma giant Pfizer has already developed and manufactured ingredients for a COVID-19 vaccine targeting the highly contagious Delta variant.
New antibodies may lead to a norovirus vaccine
Researchers have discovered antibodies that neutralize a variety of norovirus strains, a possible step toward an effective norovirus vaccine.
New vaccines may use AI to hit a moving target
Can AI create vaccines that work against mutations that haven't happened yet, groups of viruses, and virus too tricky to currently stop?